These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8795650)

  • 21. [Urinary and sexual disorders following localised prostate cancer management].
    Haab F; Beley S; Cornu JN; Culine S; Cussenot O; Hennequin C
    Bull Cancer; 2010 Dec; 97(12):1537-49. PubMed ID: 21220229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing adverse effects of treatments for prostate cancer.
    Prescrire Int; 2012 Oct; 21(131):245. PubMed ID: 23185850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local recurrence after primary therapy for clinically localized prostate cancer: is radiation or surgery "Better" in the salvage setting?
    Wood CG
    J Surg Oncol; 2008 Apr; 97(5):376. PubMed ID: 18360819
    [No Abstract]   [Full Text] [Related]  

  • 24. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.
    Boorjian SA; Eastham JA; Graefen M; Guillonneau B; Karnes RJ; Moul JW; Schaeffer EM; Stief C; Zorn KC
    Eur Urol; 2012 Apr; 61(4):664-75. PubMed ID: 22169079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential treatment for recurrent localized prostate cancer.
    Van Der Poel HG; Moonen L; Horenblas S
    J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in patients with prostate cancer.
    McPherson CP; Swenson KK; Kjellberg J
    Semin Oncol Nurs; 2001 May; 17(2):138-46. PubMed ID: 11383245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complications from treatment for prostate carcinoma among men in the Detroit area.
    Schwartz K; Bunner S; Bearer R; Severson RK
    Cancer; 2002 Jul; 95(1):82-9. PubMed ID: 12115320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Critical review of use of radiation as initial treatment for localized prostate cancer].
    Esquena S; Sánchez-Martín FM; Palou Redorta J; Rosales Bordes A; Rodríguez-Faba O; Villavicencio Mavrich H
    Actas Urol Esp; 2010 Jan; 34(1):6-9. PubMed ID: 20223126
    [No Abstract]   [Full Text] [Related]  

  • 30. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life experiences of Brazilian men with urinary incontinence and erectile dysfunction following radical prostatectomy.
    de Moraes Lopes MH; Higa R; Cordeiro SN; Rodrigues Estapê NA; Levi D'ancona CA; Turato ER
    J Wound Ostomy Continence Nurs; 2012; 39(1):90-4. PubMed ID: 22089764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer: 8. Urinary incontinence and erectile dysfunction.
    Hassouna MM; Heaton JP
    CMAJ; 1999 Jan; 160(1):78-86. PubMed ID: 9934350
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of a 15-Month Supervised Exercise Program on Physical and Psychological Outcomes in Prostate Cancer Patients Following Prostatectomy: The ProRehab Study.
    Zopf EM; Bloch W; Machtens S; Zumbé J; Rübben H; Marschner S; Kleinhorst C; Schulte-Frei B; Herich L; Felsch M; Predel HG; Braun M; Baumann FT
    Integr Cancer Ther; 2015 Sep; 14(5):409-18. PubMed ID: 25917814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
    Ficarra V; Borghesi M; Suardi N; De Naeyer G; Novara G; Schatteman P; De Groote R; Carpentier P; Mottrie A
    BJU Int; 2013 Aug; 112(3):338-45. PubMed ID: 23470027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment of locally confined prostatic carcinoma: radiotherapy versus total prostatectomy (author's transl)].
    Schröder FH; Jellinghaus W; Frohmüller H
    Urologe A; 1976 Mar; 15(2):67-72. PubMed ID: 772913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is radical prostatectomy the "gold standard" for localized prostate cancer?
    Mendenhall WM; Nichols RC; Henderson R; Mendenhall NP
    Am J Clin Oncol; 2010 Oct; 33(5):511-5. PubMed ID: 20010078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
    Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG
    Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments.
    van Stam MA; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Aaronson NK; Ruud Bosch JLH
    BJU Int; 2018 Mar; 121(3):405-414. PubMed ID: 28960827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Side effects and quality of life in prostate cancer following treatment].
    Nakada T; Kubota Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():437-45. PubMed ID: 11022766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.